Pro Medicus (ASX:PME) share price rockets 16% on earnings beat

This healthcare technology company's shares were the best performers on the ASX 200 today…

| More on:
happy woman throws arms in the air

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

The Pro Medicus Limited (ASX: PME) share price was the standout performer on the S&P/ASX 200 Index (ASX: XJO) on Thursday.

The healthcare technology company's shares were up as much as 16.5% to a record high of $65.90 before finishing the day up 15.5%.

The Pro Medicus share price is now up 86% since the start of the year.

Why did the Pro Medicus share price rocket higher?

Investors were bidding the Pro Medicus share price higher following the release of an impressive full year result this morning.

For the 12 months ended 30 June, the company reported a 19.5% increase in revenue to $67.9 million and a 43% jump in earnings before interest and tax (EBIT) to $42.7 million.

This was driven by the implementation of a series of major contract wins and further operating leverage.

Also giving the Pro Medicus share price a boost were comments by management. It advised that although FY 2021 was a record year on new contracts, its pipeline remains very healthy in respect to quality and quantity.

How does this compare to expectations?

Although its revenue fell a touch short of the market's expectation of $70 million, this was largely due to foreign exchange headwinds.

Positively, despite its revenue missing, its EBIT was ahead of the consensus estimate of $41.6 million thanks to stronger than expected margin expansion.

Goldman Sachs has commented on the result. It said: "Group revenue of $67.9m fell -3% short of consensus expectations as revenue growth for the core PACS segment of +18% (to $55.3m) fell short of our expectations of +26% (to $59.0m). However, on a constant currency basis, revenue grew +30% to $74.0m, likely explaining the majority/all of the miss."

"Furthermore, EBIT grew +43%, coming in +3% ahead of expectations, as margins increased +1,036bps (vs. cons +690bps). Net income grew +34% to $30.9m and period-end cash grew +42% to $61.8m, and the company remains debt-free."

Is it too late to invest?

Goldman Sachs currently has a neutral rating and $55.60 price target on its shares. This compares to the current Pro Medicus share price of $65.35.

However, it has yet to update its model to reflect this result. So, there's a chance in the coming days it could lift its price target higher. Investors may want to stay tuned for that one.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on 52-Week Highs

Man pointing an upward line on a bar graph symbolising a rising share price.
52-Week Highs

8 ASX 200 shares hitting multi-year highs today

These shares have defied the trend, hitting new price milestones amid a day in the red for the ASX 200.

Read more »

A happy young couple celebrate a win by jumping high above their new sofa.
52-Week Highs

Guess which ASX 200 furniture retailer is up 400% in 5 years?

Up 400% over the past five years is not bad for a furniture retailer. Here's why this quiet compounder has…

Read more »

A piggy bank on the cloud in the blue sky symbolising a record high share price.
52-Week Highs

12 ASX 200 shares that smashed historical peak prices today

Twelve ASX 200 shares rose to new multi-year peaks in an otherwise quiet day of trading.

Read more »

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
52-Week Highs

8 ASX 200 stocks striking multi-year highs today

These shares hit new price milestones amid a day in the green for the ASX 200.

Read more »

Five businessmen in suits walking up stairs in neat succession.
52-Week Highs

5 ASX 200 shares smashing new 52-week highs today

These five ASX 200 shares just broke into new multi-year and all-time highs. Here’s why.

Read more »

A mother and her young son are lying on the floor of their lounge sharing a tech device.
Technology Shares

Life360 shares are up more than 1,300% in 5 years. How does it compare to other apps?

Can Life360 compete with the likes of Facebook and Instagram?

Read more »

Emotional euphoric young woman giving high five to male partner, celebrating family achievement, getting bank loan approval, or financial or investing success.
52-Week Highs

5 ASX 200 shares hitting multi-year highs after strongly rebounding from tariff turmoil

These stocks have hit new price milestones amid a day in the green for the ASX 200.

Read more »

Woman laying with $100 notes around her, symbolising dividends.
52-Week Highs

Which ASX All Ords stock recently became a 10-bagger in 5 years?

Landing a 10-bagger is every investor's dream.

Read more »